Allow expedited FDA approval or exemption for experimental use of Aethlon Medical's Hemopurifier biofiltration device for the treatment of Ebola in advanced-staged patients. The device is a dialysis like system designed to remove viral proteins from the blood stream. It is currently in use in Germany in the treatment of a patient infected with Ebola.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
